Minimally invasive surgery procedures are of utmost relevance in clinical practice. However, the associated mechanical stress on the material poses a challenge for new implant developments. In particular PLLA, one of the most widely used polymeric biomaterials, is limited in its application due to its high brittleness and low elasticity. In this context, blending is a conventional method of improving the performance of polymer materials. However, in implant applications and development, material selection is usually limited to the use of medical grade polymers. The focus of this work was to investigate the extent to which blending poly-l-lactide (PLLA) with low contents of a selection of five commercially available medical grade polyurethanes leads to enhanced material properties. The materials obtained by melt blending were characterized in terms of their morphology and thermal properties, and the mechanical performance of the blends was evaluated taking into account physiological conditions. From these data, we found that mixing PLLA with Pellethane 80A is a promising approach to improve the material's performance, particularly for stent applications. It was found that PLLA/Pellethane blend with 10% polyurethane exhibits considerable plastic deformation before fracture, while pure PLLA fractures with almost no deformation. Furthermore, the addition of Pellethane only leads to a moderate reduction in elongation at yield and yield stress. In addition, dynamic mechanical analysis for three different PLLA/Pellethane ratios was performed to investigate thermally induced shape retention and shape recovery of the blends.

Finite element analysis (FEA) is common in biomedical engineering for combining design and material development, with model validation crucial for accurate prediction of material behavior. Simplified geometries are commonly needed in stent development due to high effort in prototype manufacturing. This study outlines a methodology for FEA validation related to stent development-related FEA validation using injection-molded planar 2D substructures from a stent design with two types of polymers: poly(l-lactide) (PLLA) and poly(glycolide-co-trimethylene carbonate) (PGA-co-TMC). Specimens underwent quasi-static and cyclic testing, including loading, stress relaxation, unloading, and strain recovery. The material model coefficients for FEA were calibrated for three different constitutive models: linear elastic–plastic (LEP), Parallel Rheological Framework (PRF), and Three-Network (TN) model. The validation of planar stent segment expansion (PSSE) showed strong agreement with the experiments in deformation patterns, with varying force–displacement responses. The PRF and TN models provided better fits for behavioral predictions, with the PRF model being especially favorable for PLLA, while all models exhibited limitations for PGA-co-TMC. This study proposes a robust approach for the material modeling in stent development, enabling efficient material screening and stent design optimization through a simplified 2D validation setup. Material model accuracy depends strongly on calibration–load case congruence, while phenomenological approaches (PRF) show enhanced model robustness against load case variations compared to physically coupled models (TN).

Degradable polymers, such as poly(L-lactide) (PLLA), are widely investigated for biomedical applications, including drug delivery systems and temporary implants. Their functionality can be expanded by incorporating degradable metal microparticles that may influence degradation behaviour and enable additional surface modification strategies. In this study, the feasibility of composites consisting of PLLA and biodegradable iron microparticles was investigated. Composites were fabricated by solvent casting, providing a gentle alternative to thermal processing methods, which often compromise polymer integrity. Composites were evaluated by thermogravimetric analysis, differential scanning calorimetry, scanning electron microscopy (SEM), tensile testing, dynamic mechanical analysis, and X-ray photoelectron spectroscopy (XPS). Incorporation of iron altered thermal behaviour and crystallinity of PLLA, indicating interactions between polymer matrix and dispersed metal phase that may affect degradation kinetics and material stability. While iron addition reduced Young’s modulus, tensile strength, and elongation at break, composites maintained sufficient structural integrity for potential biomedical applications. XPS and SEM confirmed the embedding of particles within the polymer matrix, enabling potential post-processing approaches. In vitro direct contact and eluate tests demonstrated good cell viability, whereas exposure to free iron particles resulted in dose- and time-dependent cytotoxic effects. Overall, the results demonstrate the feasibility of solvent-cast PLLA–iron composites for resorbable biomedical applications.